In bladder cancer, TLR2 and TLR4 would be activated by the cell wall component of M. tuberculosis, further inducing the inflammatory responses and laying the theoretical foundation for the anti-cancer effect of BCG intravesical instillation therapy in bladder cancer (175). This evidence concerns the gene TLR4 and urinary bladder carcinoma.